Skip to main content
. 2023 Sep 21;22:258. doi: 10.1186/s12933-023-01984-4

Table 1.

Baseline characteristics of participants with hypertension by cumulative RC quartiles

Total Q1
(< 26.40 mg/dl)
Q2
(26.40-39.56 mg/dl)
Q3
(39.57-54.65 mg/dl)
Q4
(≥ 54.66 mg/dl)
*P value
Participants 14,349 3587 3587 3588 3587 /
Age (years) 56.05 ± 10.29 55.59 ± 10.81 56.07 ± 9.38 56.11 ± 10.18 56.44 ± 10.74 0.02
Male, N (%) 11,771(82.0) 3041(84.8) 2974 (82.9) 2856(79.6) 2900(80.8) < 0.01
BMI (kg/m2 ) 26.06 ± 3.41 25.47 ± 3.34 26.17 ± 3.45 26.13 ± 3.46 26.45 ± 3.30 < 0.01
SBP (mmHg) 141.77 ± 19.08 142.09 ± 19.56 140.96 ± 19.42 141.85 ± 19.12 142.19 ± 8.16 < 0.01
DBP (mmHg) 89.66 ± 10.87 89.14 ± 10.93 89.63 ± 11.07 89.93 ± 10.45 89.95 ± 10.99 < 0.01
HDL-C (mg/dl) 57.44 ± 15.87 60.53 ± 15.43 56.71 ± 15.02 56.31 ± 15.72 56.21 ± 16.87 < 0.01
LDL-C (mg/dl) 101.20 ± 31.91 103.54 ± 27.54 104.99 ± 28.52 101.02 ± 32.71 95.25 ± 37.10 < 0.01
*TG (mg/dl) 53.90(37.73–80.85) 36.58(26.95–48.90) 53.90(40.43–73.54) 53.90(42.35–85.86) 77.00(51.98-120.89) < 0.01
*RC2006(mg/dl) 45.43(25.03–71.61) 20.02(14.25–28.49) 38.50(26.56–52.75) 56.21(40.81–73.15) 84.70(62.37-112.42) < 0.01
*RC2008(mg/dl) 32.34(19.63–53.90) 16.48(11.94–21.56) 29.26(22.33–36.96) 45.43(31.96–57.37) 67.76(46.20-87.01) < 0.01
*RC2010(mg/dl) 29.65(16.56–54.29) 16.56(11.55–23.87) 26.95(16.56–41.20) 36.19(20.02–57.75) 61.98(37.35–93.17) < 0.01
*Cum-RC(mg/dl) 39.63(26.49–55.49) 19.72(15.64–23.17) 32.92(29.79–36.04) 46.89(43.17–50.59) 68.70(61.03–80.43) < 0.01
FPG (mmol/L) 5.92 ± 1.95 5.65 ± 1.48 5.87 ± 1.69 5.98 ± 1.79 6.18 ± 2.60 < 0.01
*hs-CRP (mg/L) 1.40(0.62–3.20) 1.40(0.70-3.00) 1.30(0.55-3.00) 1.40(0.60–3.26) 1.30(0.66–3.63) < 0.01
eGFR(ml/min/1.73m2) 84.73 ± 18.76 79.39 ± 18.64 83.78 ± 18.58 87.06 ± 18.35 88.70 ± 18.10 < 0.01
Current smoker, N (%) 5434(37.9) 1127(31.4) 1389(38.7) 1443(40.2) 1475(41.1) < 0.01
Alcohol drinker, N (%) 4999(34.8) 1037(28.9) 1233(34.4) 1331(37.1) 1398(39.0) < 0.01
Physical activity, N (%) 2151(15.0) 509(14.2) 606(16.9) 564(15.7) 472(13.2) < 0.01
Education, N (%) 2669(18.6) 591(16.5) 776(21.6) 681(19.0) 621(17.3) < 0.01
Diabetes, N (%) 2335(16.3) 415(11.6) 535(14.9) 608(16.9) 777(21.7) < 0.01
Antihypertensive drugs, N (%) 4372(30.5) 980(27.3) 1118(31.2) 1117(31.1) 1157(32.3) < 0.01
Hypoglycemic drugs, N (%) 1164(8.11) 185(5.16) 266(7.42) 309(8.61) 404(11.3) < 0.01
Lipid-lowering drugs, N (%) 195(1.36) 16(0.45) 39(1.09) 57(1.59) 83(2.31) < 0.01

BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, FPG fasting plasma glucose, TG triglyceride, hs-CRP high-sensitivity C reactive protein,eGFR estimated glomerular filtration rate, RC remant cholesterol, Cum-RC cumulative remant cholesterol

*P value, comparison of baseline characteristics between diferent Cum-RC groups

*TG, hs-CRP, RC2006, RC2008, RC2010 and Cum-RC were expressed by median (IQR)